Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression
ConclusionRP11-567G11.1 plays a crucial role in pancreatic cancer. Importantly, depletion of RP11-567G11.1 boosts the sensitivity of pancreatic cancer cells to gemcitabine, suggesting that this lncRNA is a promising target for pancreatic cancer treatment.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Pancreas | Pancreatic Cancer | Stem Cell Therapy | Stem Cells | Study